Renal Cell Carcinoma

  • Michael A. GarciaEmail author
  • Alexander R. Gottschalk


This chapter will discuss diagnosis, staging, and management of renal cell carcinoma.


Renal cell carcinoma Kidney cancer Nephrectomy Stereotactic body radiation therapy 



The authors thank Sunanda Pejavar MD and James Rembert MD for their work on the prior edition of this chapter.


  1. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (editos). AJCC cancer staging manual, 8th edition. Springer; 2017Google Scholar
  2. Dabestani S, Marconi L, Hofmann F, et al. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol. 2014;15(12):e549–61.CrossRefGoogle Scholar
  3. Edge SB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, (editors). AJCC cancer staging manual, 7th edition. Springer; 2010Google Scholar
  5. Kao GD, Malkowicz SB, Whittington R, et al. Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy planned with CT. Radiology. 1994;193(3):725–30.CrossRefGoogle Scholar
  6. Kothari G, Foroudi F, Gill S, Corcoran NM, Siva S. Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review. Acta Oncol. 2015;54(2):148–57.CrossRefGoogle Scholar
  7. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: kidney cancer. Available at: Accessed 3 Aug 2016.
  8. Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int. 2012;110(11 Pt B):E737–43.CrossRefGoogle Scholar
  9. Siva S, Ellis RJ, Ponsky L, et al. Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma. Future Oncol. 2016;12(5):637–45.CrossRefGoogle Scholar
  10. Stein M, Kuten A, Halpern J, et al. The value of postoperative irradiation in renal cell cancer. Radiother Oncol. 1992;24(1):41–4.CrossRefGoogle Scholar
  11. Tunio MA, Hashmi A, Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol. 2010;21(9):1839–45.CrossRefGoogle Scholar
  12. Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner K-M, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol. 2006;45(4):493–7.CrossRefGoogle Scholar
  13. Zelefsky MJ, Greco C, Motzer R, et al. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1744–8.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiation Oncology, University of California San FranciscoSan FranciscoUSA
  2. 2.Department of Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations